These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 20799259)

  • 61. Adjusting for observational secondary treatments in estimating the effects of randomized treatments.
    Zhang M; Wang Y
    Biostatistics; 2013 Jul; 14(3):491-501. PubMed ID: 23349243
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The analysis of competing events like cause-specific mortality--beware of the Kaplan-Meier method.
    Verduijn M; Grootendorst DC; Dekker FW; Jager KJ; le Cessie S
    Nephrol Dial Transplant; 2011 Jan; 26(1):56-61. PubMed ID: 21059831
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Adaptive truncated weighting for improving marginal structural model estimation of treatment effects informally censored by subsequent therapy.
    Bai X; Liu J; Li L; Faries D
    Pharm Stat; 2015; 14(6):448-54. PubMed ID: 26436533
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Adaptive design: estimation and inference with censored data in a semiparametric model.
    Shen Y; Cheng Y
    Biostatistics; 2007 Apr; 8(2):306-22. PubMed ID: 16787996
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Analysis of covariance with pre-treatment measurements in randomized trials: comparison of equal and unequal slopes.
    Funatogawa I; Funatogawa T
    Biom J; 2011 Sep; 53(5):810-21. PubMed ID: 21887795
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Five interval estimators of the risk difference under stratified randomized clinical trials with noncompliance and repeated measurements.
    Lui KJ; Chang KC
    J Biopharm Stat; 2013; 23(4):756-73. PubMed ID: 23786643
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A robust weighted Kaplan-Meier approach for data with dependent censoring using linear combinations of prognostic covariates.
    Hsu CH; Taylor JM
    Stat Med; 2010 Sep; 29(21):2215-23. PubMed ID: 20812302
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Robust versus consistent variance estimators in marginal structural Cox models.
    Enders D; Engel S; Linder R; Pigeot I
    Stat Med; 2018 Oct; 37(24):3455-3470. PubMed ID: 29888510
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data.
    Xie J; Liu C
    Stat Med; 2005 Oct; 24(20):3089-110. PubMed ID: 16189810
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Estimation of attributable fractions using inverse probability weighting.
    Sjölander A
    Stat Methods Med Res; 2011 Aug; 20(4):415-28. PubMed ID: 20223785
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Doubly robust inference for targeted minimum loss-based estimation in randomized trials with missing outcome data.
    Díaz I; van der Laan MJ
    Stat Med; 2017 Oct; 36(24):3807-3819. PubMed ID: 28744883
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Estimation of survival distributions of treatment policies in two-stage randomization designs in clinical trials.
    Lunceford JK; Davidian M; Tsiatis AA
    Biometrics; 2002 Mar; 58(1):48-57. PubMed ID: 11890326
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Analysis of recurrent gap time data using the weighted risk-set method and the modified within-cluster resampling method.
    Luo X; Huang CY
    Stat Med; 2011 Feb; 30(4):301-11. PubMed ID: 20963733
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Estimation of a decreasing hazard of patients with acute coronary syndrome.
    van Geloven N; Martin I; Damman P; de Winter RJ; Tijssen JG; Lopuhaä HP
    Stat Med; 2013 Mar; 32(7):1223-38. PubMed ID: 22829475
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of adaptive treatment strategies based on longitudinal outcomes in sequential multiple assignment randomized trials.
    Li Z
    Stat Med; 2017 Feb; 36(3):403-415. PubMed ID: 27646957
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Fair comparisons of cause-specific and relative survival by accounting for the systematic removal of patients from risk-sets.
    Wells M; Rutherford MJ; Lambert PC
    Cancer Epidemiol; 2023 Oct; 86():102408. PubMed ID: 37591148
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Bias in retrospective analyses of biomarker effect using data from an outcome-adaptive randomized trial.
    Ji L; McShane LM; Krailo M; Sposto R
    Clin Trials; 2019 Dec; 16(6):599-609. PubMed ID: 31581815
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Causal inference on quantiles with an obstetric application.
    Zhang Z; Chen Z; Troendle JF; Zhang J
    Biometrics; 2012 Sep; 68(3):697-706. PubMed ID: 22150612
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Doubly robust estimator of risk in the presence of censoring dependent on time-varying covariates: application to a primary prevention trial for coronary events with pravastatin.
    Kawahara T; Shinozaki T; Matsuyama Y
    BMC Med Res Methodol; 2020 Jul; 20(1):204. PubMed ID: 32736528
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Information estimators for weighted observations.
    Hino H; Murata N
    Neural Netw; 2013 Oct; 46():260-75. PubMed ID: 23859828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.